HOME > Corporate Information > Content of Business

Content of Business

 TRANS GENIC has two business groups: “Life science-related business group” and “Investment/ consulting business group”.
 In Life science-related business group, we develop genomics business based on knockout mouse production technology and high-affinity antibody production. Furthermore, subsidiaries of TRANS GENIC conduct following services: New Drug Research Center, Inc. and Biosafety Research Center Inc. provides non-clinical test service, and GeneticLab Co., LTD., executes gene analysis and histopathological diagnosis.
 TRANS GENIC Group supports life science industry totally including basic research, research and development on medical agents and antibody drug, and pathological tissue diagnostics directly linked to clinical medicine.
 In Investment/ consulting business group, TG Business Service Inc., affiliate company of TRANS GENIC, provides support and advice on business succession and regeneration in wide range of areas, and carries out M&A.

Business Overview

Each business

Genomics business
Genomics business
 In Genomics business, TRANS GENIC lead the market as a pioneer of genetically engineered mouse production service. We have achieved results, earned trusts, and realized high success rate by adopting cutting-edge technologies. Moreover, we provide useful mouse models, such as various kinds of disease-visualized mouse.
Non-clinical test service using genetically engineered mouse is also available in collaboration with CRO business. It is a unique service of TRANS GENIC, and contributes to develop competitive advantage. In addition, we provide contract-based high affinity monoclonal antibody production service and research reagent distribution service.
CRO business
CRO business
 In CRO business, TRANS GENIC conducts contract-based non-clinical test service in order to accommodate customer needs. The service includes drug efficiency and pharmacological tests, safety pharmacological study and pharmacokinetic study, utilizing wide variety of animals form small animals to primates in GLP- and GCP-certified facilities and AAALAC-full accredited facilities.
We provide high-quality and wide variety of non-clinical test services backed by the business achievements over the years. Now, TRANS GENIC is recognized for providing best solution for customers by high-level consulting. Contract-based clinical trial service regarding medical agents and foods is also available.
Advanced medical business
Advanced medical business
 In Advanced medical business, TRANS GENIC provides contract-based gene analysis service, molecular pathological analysis service, which is the fusion of gene analysis technology and pathological diagnosis technology, and protein quantification analysis service. We also support drug discovery in preparation for individualized medicine through cancer clinical sequencing. In particular, our molecular pathological analysis has high demand for pharmaceutical companies, and is recognized as high-quality service with technical capability.     
Pathological diagnosis business
Pathological diagnosis business
 Full-time certified pathologists, who make pathological cytodiagnosis for more than hundred thousand times in a year, provide high-quality pathological tissue diagnosis and ISH/FSH analysis using established probes in the global standard certified (CAP) facilities. Combination use of liquid based cytology and HPV nucleic acid detection test is also available for the purpose of improving detection rate of cervical cancer.    
TGBS business
TGBS business
 TG Business Service Inc., affiliate company of TRANS GENIC, provides support and advice on business succession and regeneration in wide range of areas, and carries out M&A.    
  • Press Releases
Contact us/Products & ServiceE-mail
  • Reproductive Technology Training
Back to Top